Elizabeth Charlotte Christian, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Interferon | 1 | 2024 | 114 | 0.220 |
Why?
|
| Heterozygote | 1 | 2024 | 2794 | 0.140 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2016 | 329 | 0.100 |
Why?
|
| Milk, Human | 1 | 2016 | 490 | 0.100 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 2011 | 95 | 0.090 |
Why?
|
| SAIDS Vaccines | 1 | 2010 | 144 | 0.080 |
Why?
|
| Mammary Glands, Animal | 1 | 2010 | 272 | 0.080 |
Why?
|
| Lactation | 1 | 2010 | 391 | 0.070 |
Why?
|
| Immunization, Secondary | 1 | 2010 | 373 | 0.070 |
Why?
|
| Protein Engineering | 1 | 2011 | 550 | 0.070 |
Why?
|
| Immunity, Cellular | 1 | 2010 | 1555 | 0.060 |
Why?
|
| HIV Antibodies | 1 | 2011 | 1337 | 0.060 |
Why?
|
| DNA, Viral | 1 | 2010 | 2199 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2016 | 3242 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2010 | 3404 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 2010 | 0.040 |
Why?
|
| Mutation | 1 | 2024 | 30198 | 0.040 |
Why?
|
| Illinois | 1 | 2016 | 120 | 0.030 |
Why?
|
| Infant Care | 1 | 2016 | 181 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 9249 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2016 | 410 | 0.030 |
Why?
|
| HIV-1 | 1 | 2011 | 6944 | 0.030 |
Why?
|
| Gene Products, pol | 1 | 2010 | 43 | 0.020 |
Why?
|
| Poxviridae | 1 | 2010 | 37 | 0.020 |
Why?
|
| Molecular Typing | 1 | 2011 | 115 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 2010 | 455 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 2010 | 317 | 0.020 |
Why?
|
| Gene Products, env | 1 | 2010 | 251 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2016 | 855 | 0.020 |
Why?
|
| Vaccines, Attenuated | 1 | 2010 | 312 | 0.020 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2011 | 306 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2011 | 735 | 0.020 |
Why?
|
| Birth Weight | 1 | 2016 | 2121 | 0.020 |
Why?
|
| Gestational Age | 1 | 2016 | 3609 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2016 | 2122 | 0.020 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2011 | 923 | 0.020 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2010 | 543 | 0.020 |
Why?
|
| Mothers | 1 | 2016 | 2210 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 2274 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 4165 | 0.020 |
Why?
|
| HIV Infections | 1 | 2011 | 17533 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3750 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2010 | 2341 | 0.010 |
Why?
|
| Phylogeny | 1 | 2011 | 2832 | 0.010 |
Why?
|
| Transfection | 1 | 2011 | 5743 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2010 | 1811 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 13400 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2010 | 3211 | 0.010 |
Why?
|
| Protein Binding | 1 | 2011 | 9296 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 17594 | 0.010 |
Why?
|
| Cell Line | 1 | 2011 | 15543 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 26346 | 0.010 |
Why?
|
| Female | 3 | 2024 | 396112 | 0.010 |
Why?
|
| Male | 2 | 2024 | 363698 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 54802 | 0.010 |
Why?
|
| Humans | 3 | 2024 | 765968 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 74840 | 0.010 |
Why?
|
| Animals | 1 | 2010 | 168764 | 0.000 |
Why?
|